This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Universiti Putra Malaysia. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Aini Ideris: Innovator in Antiviral Peptide Research
Introduction
Aini Ideris is a notable inventor based in Serdang, Malaysia. He has made significant contributions to the field of antiviral research, particularly in developing solutions against avian influenza virus H9N2. His innovative work has the potential to impact public health and poultry industries significantly.
Latest Patents
Aini Ideris holds a patent for an "Antiviral peptide against avian influenza virus H9N2." This invention involves recombinant phages carrying fusion peptides that bind to avian influenza virus (AIV). These phages serve as diagnostic reagents, replacing anti-AIV antibodies by competing for binding sites on the virus. The synthetic peptides with the sequence CNDFRSKTC, whether in linear or cyclic forms, have shown effectiveness in inhibiting AIV propagation in embryonated eggs and MDCK cell lines. This innovation may serve as a therapeutic agent to control, treat, and eradicate bird flu caused by avian influenza virus.
Career Highlights
Aini Ideris is affiliated with Universiti Putra Malaysia, where he continues to advance his research in virology and peptide technology. His work is crucial in addressing the challenges posed by avian influenza and enhancing diagnostic methods.
Collaborations
Aini collaborates with esteemed colleagues, including Khatijah Mohd Yusoff and Mohamed Rajik. Their combined expertise contributes to the advancement of research in the field of antiviral peptides.
Conclusion
Aini Ideris is a pioneering inventor whose work on antiviral peptides against avian influenza virus H9N2 showcases the importance of innovation in public health. His contributions are vital in the ongoing fight against viral infections in poultry and beyond.